Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, shared Thomas Ichim’s, President and Chief Scientific Officer at Immorta Bio, post on X, adding:
“Thank you for sharing this important difference between IL-2 and IL-15.
This error of insight had led to the development for decades of the wrong cytokine… one stimulates suppressor cells while the other killer cells!
Important paper to read and understand.”
Quoting Thomas Ichim’s post:
“All the real cancer immunotherapy experts know that IL-15 anktiva by Immunitybio Inc is the biggest breakthrough in this field.”
Title: Advances in IL–15–Based Cancer Immunotherapy and Divergent Immunological Effects of IL–2 and IL–15 Signaling via the Shared IL–2Rβγ Receptor
Authors: Huiquan Gao, Tao Ma, Qinqin Jiang, Lanfang Gao, Jinfang Li, Shubo Wang, Ziyong Liu, Zhixin Zhang, Gang Wu, Wenxin He, Fuxin Zhou
Patrick Soon-Shiong was recognized among OncoDaily’s ‘The 100 Most Influential People in Oncology in 2025 (Full List)’, highlighting their contributions to the field of oncology.
Nominations for ‘100 Influential People in Oncology 2026’ are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit Your Nomination by September 15.
